Search Results 1311-1320 of 38988 for ms

  1. Publications - Kaaren K. Reichard, M.D. - Mayo Clinic

    Rana MS, Iftikhar M, Jadoon Y, Abdelmagid M, Viswanatha DS, He R, Reichard KK, Pardanani AD, Gangat N, Tefferi A. The Mutational Landscape in Polycythemia ...

  2. Medical Research & Education - Mayo Clinic News Network

    Julie Vera, M.S.. October 17, 2022. New Mayo Clinic Proceedings expansion journal will focus on health care's digital transformation featured image. Featured ...

  3. Dominique B. Hoelzinger, Ph.D. - Mayo Clinic Faculty Profiles

    EDUCATION. PhD - Molecular and Cellular Biology Arizona State University; MS - Molecular and Cellular Biology Arizona State University; MS - Zoology and Botany ...

  4. Publications - Leila M. Tolaymat, M.D. - Mayo Clinic

    Berman H, Shimshak S, Reimer D, Brigham T, Hedges MS, Degesys C, Tolaymat L. Skin Cancer in Solid Organ Transplant Recipients: A Review for the Nondermatologist ...

  5. Faculty - Department of Physiology and Biomedical Engineering - Mayo Clinic Research

    D., M.S. · smith.joshua1@mayo.edu; Assistant Professor of Medicine; Publications · Smith-Edwards, Kristen M.

  6. Vivek Nagaraja, M.B.B.S., M.D.

    Nagaraja attended medical school at M.S. Ramaiah Medical College in Bangalore, India. He did an extended internship training in United Kingdom. He obtained ...

  7. Jun Zhang, M.D. - Mayo Clinic Faculty Profiles

    MS Department of Pathology, Peking (Beijing) Union Medical College Hospital; MD Xu Zhou Medical University. src="/-/media/kcms/gbs/research/images/. Clinical ...

  8. Movement disorders - Symptoms and causes - Mayo Clinic

    Thyroid conditions, multiple sclerosis, stroke, viral encephalitis and several others can cause movement disorders. Brain tumors also can lead to movement ...

  9. Medical Research & Education - Mayo Clinic News Network

    Julie Ann Vera, M.S.. October 20, 2023. Mayo Clinic Proceedings, Kidney International publish consensus statement on new approach to identifying kidney ...

  10. Publications - Robert R. McWilliams, M.D. - Mayo Clinic

    ... MS. NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma. Eur J Cancer. 2025 Sep 9; 227 ...